readthroughSign in
CompanyDCOYNasdaqHouston, TX

Salarius Pharmaceuticals, LLC

Decoy Therapeutics develops peptide antivirals designed to target multiple respiratory viruses using its IMP(3)ACT platform, which combines AI-assisted design and rapid synthesis.

SCHEDULE 13G/ANov 16Latest SEC filing
Oct 7Latest story